View Profile

Ms. Twinkle Gupta

Assistant Professor, School of Pharmacy · Mody University of Science and Technology, Laxmangarh

https://researchid.co/twinklegupta
@modyuniversity.ac.in
28Google Scholar Citations
3Google Scholar h-index
2Google Scholar i10-index

Research Interests

Nanomedicine, Nano-formulation Development, Drug Delivery, Cancer

Biography

She is an enthusiastic academician and researcher in Pharmaceutical Biotechnology, with 2.7 years of teaching experience. She is currently working as an Assistant Professor at Mody University of Science and Technology, Lacchmangarh, Rajasthan, where she is actively engaged in teaching, mentoring students, and pursuing research in advanced pharmaceutical sciences. Her research expertise lies in nanocarrier-based drug delivery, computational drug design, molecular biology, and analytical instrumentation. She has qualified GPAT and DHSGSU (2020) and published her work in reputed journals, including Mini-Reviews in Medicinal Chemistry, Anti-Cancer Agents in Medicinal Chemistry, and Future Journal of Pharmaceutical Sciences (Springer Nature). She is also filed patent for her innovative work on the “Treatment of Multiple Sclerosis through Structural Modification of P2X4 Receptor."

Education

B. Pharm., Sagar Institute of Pharmaceutical, Sciences College, Sagar (M.P) Affiliated with RGPV, 2016-2020, M. Pharm, Pharmaceutical Biotechnology, Dr. Harisingh Gour University Sagar (M.P), 2020-2022,

Recent Google Scholar Publications

  1. Advances in Microscopy Techniques for Biochemical Interactions and Cellular Imaging
    International Journal of Scientific Research and Technology 3 (10), 304-312 , 2025, 2025
  2. Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
    Future Journal of Pharmaceutical Sciences 10 (1), 19 , 2024, 2024 | Citations: 14.0
  3. A comprehensive review on nanoparticles as a targeted delivery system for the treatment of lung cancer
    Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 24 (3), 157-168 , 2024, 2024 | Citations: 3.0
  4. Structural insight on GPR119 agonist as potential therapy for type II diabetes: a comprehensive review
    Mini Reviews in Medicinal Chemistry 23 (21), 2008-2040 , 2023, 2023 | Citations: 11.0

Research Outputs

• Patent on “Treatment of multiple sclerosis through structural modification of P2X4 receptor” (Application number – 202331039169)

Links